Matthew Korenberg - 13 Dec 2024 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
CFO, Treasurer
Signature
/s/ Kathleen A. McGowan, Attorney-in-Fact
Issuer symbol
PVLA
Transactions as of
13 Dec 2024
Transactions value $
$0
Form type
4
Filing time
17 Dec 2024, 20:43:01 UTC
Previous filing
24 Sep 2024
Next filing
10 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PVLA Stock Option (right to buy) Award $0 +167,100 $0 167,100 13 Dec 2024 Common Stock 167,100 $13.6 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the stock options will vest on October 16, 2025, and the remaining 75% will vest in equal monthly tranches over the following 36 months.